BackTelomir Pharmaceuticals Overview
Telomir Pharmaceuticals Inc

Telomir Pharmaceuticals Target Price

See Telomir Pharmaceuticals's analyst price targets ($4) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$0.88

Average Target Price

$4.00357.1% upside

1 analysts in the last 4 months

High: $4 | Low: $4

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-17Maxim Group$4357.1% upsideOpen

Telomir Pharmaceuticals (TELO) FAQ

Telomir Pharmaceuticals (TELO) currently reports a target price of $4. Use the charts on this page to explore Telomir Pharmaceuticals's target price history and peer comparisons.

Analysts' average 12-month price target for Telomir Pharmaceuticals is $4, about 357.1% upside from the current share price of $0.88. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $4, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Telomir Pharmaceuticals, and consider following TELO for alerts when major investors trade the stock.